Molecular characterization of an intronic RNASEH2B variant in a patient with Aicardi-Goutières syndrome.

[1]  Martin A. M. Reijns,et al.  DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes , 2022, The Journal of experimental medicine.

[2]  N. Boddaert,et al.  Spectrum of Neuroradiologic Findings Associated with Monogenic Interferonopathies , 2021, American Journal of Neuroradiology.

[3]  C. Bodemer,et al.  Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I Interferonopathies , 2021, Journal of Clinical Immunology.

[4]  Martin A. M. Reijns,et al.  cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing , 2020, Nature Genetics.

[5]  A. Vanderver,et al.  Late-Onset Aicardi-Goutières Syndrome: A Characterization of Presenting Clinical Features. , 2020, Pediatric neurology.

[6]  A. Vanderver,et al.  Janus Kinase Inhibition in the Aicardi-Goutières Syndrome. , 2020, The New England journal of medicine.

[7]  T. Kaname,et al.  An extremely severe case of Aicardi-Goutières syndrome 7 with a novel variant in IFIH1. , 2020, European journal of medical genetics.

[8]  Y. Crow,et al.  Treatments in Aicardi–Goutières syndrome , 2020, Developmental medicine and child neurology.

[9]  E. Bertini,et al.  Molecular Genetics and Interferon Signature in the Italian Aicardi Goutières Syndrome Cohort: Report of 12 New Cases and Literature Review , 2019, Journal of clinical medicine.

[10]  David G. Knowles,et al.  Predicting Splicing from Primary Sequence with Deep Learning , 2019, Cell.

[11]  Y. Crow,et al.  Self-Awareness: Nucleic Acid-Driven Inflammation and the Type I Interferonopathies. , 2019, Annual review of immunology.

[12]  Y. Crow,et al.  Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome , 2018, The New England journal of medicine.

[13]  Jonathan S. Berg,et al.  Combination of exome sequencing and immune testing confirms Aicardi–Goutières syndrome type 5 in a challenging pediatric neurology case , 2018, Cold Spring Harbor molecular case studies.

[14]  Martin A. M. Reijns,et al.  RNase H2, mutated in Aicardi‐Goutières syndrome, promotes LINE‐1 retrotransposition , 2018, The EMBO journal.

[15]  F. Alkuraya,et al.  Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome: A Study of 24 Patients. , 2018, Pediatric neurology.

[16]  A. Moser,et al.  Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots. , 2017, Molecular genetics and metabolism.

[17]  Rashid Merchant,et al.  Aicardi-Goutières Syndrome , 2016, The Indian Journal of Pediatrics.

[18]  Martin A. M. Reijns,et al.  Ribonuclease H2 mutations induce a cGAS/STING‐dependent innate immune response , 2016, The EMBO journal.

[19]  Y. Crow,et al.  Aicardi–Goutières syndrome and the type I interferonopathies , 2015, Nature Reviews Immunology.

[20]  L. Lagae,et al.  Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 , 2015, American journal of medical genetics. Part A.

[21]  A. Vanderver,et al.  Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study , 2013, The Lancet Neurology.

[22]  R. Naumann,et al.  Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity , 2012, The Journal of experimental medicine.

[23]  Martin A. M. Reijns,et al.  The Structure of the Human RNase H2 Complex Defines Key Interaction Interfaces Relevant to Enzyme Function and Human Disease* , 2010, The Journal of Biological Chemistry.

[24]  C. Ponting,et al.  Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection , 2006, Nature Genetics.

[25]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.